The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core

被引:51
作者
Zhou, GF
Ferrer, M
Chopra, R
Kapoor, TM
Strassmaier, T
Weissenhorn, W
Skehel, JJ
Oprian, D
Schreiber, SL
Harrison, SC
Wiley, DC
机构
[1] Harvard Univ, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA
[2] Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA
[3] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA
[4] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[5] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA
[6] EMBL, F-38000 Grenoble, France
[7] Natl Inst Med Res, London NW7 1AA, England
[8] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA
关键词
D O I
10.1016/S0968-0896(00)00155-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The three-dimensional structure of the complex between an HIV-1 cell-entry inhibitor selected from screening a combinatorial library of non-natural building blocks and the central, trimeric, coiled-coil core of HIV-1 gp41 has been determined by Xray crystallography. The biased combinatorial library was designed to identify ligands binding in nonpolar pockets on the surface of the coiled-coil core of gp41. The crystal structure shows that the non-peptide moiety of the inhibitor binds to the targeted cavity in two different binding modes. This result suggests a strategy for increasing inhibitor potency by use of a second-generation combinatorial library designed to give simultaneous occupancy of both binding sites. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2219 / 2227
页数:9
相关论文
共 39 条
[11]   Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket [J].
Eckert, DM ;
Malashkevich, VN ;
Hong, LH ;
Carr, PA ;
Kim, PS .
CELL, 1999, 99 (01) :103-115
[12]  
Ferrer M, 1999, NAT STRUCT BIOL, V6, P953
[13]   Capture of an early fusion-active conformation of HIV-1 gp41 [J].
Furuta, RA ;
Wild, CT ;
Weng, YK ;
Weiss, CD .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (04) :276-279
[14]   A GENERAL-MODEL FOR THE TRANSMEMBRANE PROTEINS OF HIV AND OTHER RETROVIRUSES [J].
GALLAHER, WR ;
BALL, JM ;
GARRY, RF ;
GRIFFIN, MC ;
MONTELARO, RC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (04) :431-440
[15]  
HANDSCHUMACHER MD, 1999, SURFACE CCP4
[16]   HIV-1 INHIBITION BY A PEPTIDE [J].
JIANG, SB ;
LIN, K ;
STRICK, N ;
NEURATH, AR .
NATURE, 1993, 365 (6442) :113-113
[17]   Electron-density map interpretation [J].
Jones, TA ;
Kjeldgaard, M .
MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 :173-208
[18]   A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41 [J].
Joshi, SB ;
Dutch, RE ;
Lamb, RA .
VIROLOGY, 1998, 248 (01) :20-34
[19]   Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: Implications for the viral fusion mechanism [J].
Judice, JK ;
Tom, JYK ;
Huang, W ;
Wrin, T ;
Vennari, J ;
Petropoulos, CJ ;
McDowell, RS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13426-13430
[20]   Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry [J].
Kilby, JM ;
Hopkins, S ;
Venetta, TM ;
DiMassimo, B ;
Cloud, GA ;
Lee, JY ;
Alldredge, L ;
Hunter, E ;
Lambert, D ;
Bolognesi, D ;
Mathews, T ;
Johnson, MR ;
Nowak, MA ;
Shaw, GM ;
Saag, MS .
NATURE MEDICINE, 1998, 4 (11) :1302-1307